Latest Schedule 13D activist filings

Activants group of entities has updated its beneficial ownership filing for Better Home & Finance Holding Co., reflecting a decrease in ownership percentage due to an increase in outstanding shares.

Tether Global Investments Fund and its subsidiaries report an amendment to their Schedule 13D filing regarding their beneficial ownership of Versamet Royalties Corporation shares.

A group of reporting persons has amended their Schedule 13D filing to reflect their beneficial ownership of 7.5% of Citizens Community Bancorp Inc. common stock as of June 26, 2026.

Freightos founder Zvi Schreiber has disclosed a 6.1% stake and expressed concerns over the company's current strategic direction, advocating for a return to a high-growth platform-first strategy and board changes.

Forager Fund, L.P. has submitted a non-binding proposal to acquire all outstanding shares of Repay Holdings Corp. not already owned by the fund at $5.25 per share in cash.

SilverCape Investments Limited has submitted a revised non-binding proposal to acquire PetMed Express, Inc. for $3.00 per share in cash, representing a 70% premium over the recent closing price, citing the company's deteriorating financial condition and governance issues.

Sino Lion Ventures Limited and Chenhao Xu filed an amendment to their Schedule 13D regarding their 29.19% stake in Indaptus Therapeutics, Inc.

Applied Digital Corporation has established a $100 million unsecured demand grid promissory note to support ChronoScale Corp's working capital needs.

Applied Digital Corporation has established a $100 million unsecured demand grid promissory note to support ChronoScale Corp's working capital needs.

Junyi Dai reports a change in his beneficial ownership percentage of Indaptus Therapeutics due to an increase in the company's total outstanding shares.

Ting Yang filed an amendment to his Schedule 13D disclosing an 8.44% beneficial ownership stake in Indaptus Therapeutics, Inc. following a dilution event.

Yun Yao discloses a 31.51% beneficial ownership stake in Indaptus Therapeutics, Inc. following a dilution event.

Reporting persons disclose updated beneficial ownership of New England Realty Associates Limited Partnership following the settlement of Harold Brown's estate.

BVF Partners and affiliated entities sold 1,630,658 shares of Kymera Therapeutics at $106.50 per share on June 26, 2026.

A group of Series A Preferred stockholders holding 11.7% of the class is demanding a special meeting to elect two new trustees due to ongoing dividend arrearages.

Nicholas J. Swenson and the AO Partners Group have increased their beneficial ownership in Pro-Dex, Inc. to 31.88%.

RA Capital Management has disclosed a series of open market sales reducing its beneficial ownership in Werewolf Therapeutics, Inc. to 6.0%.

Eclipse Ventures and Lior Susan report a pro-rata in-kind distribution of Cerebras Systems Class A common stock.

Scilex Holding Company reports a dividend distribution of Semnur Pharmaceuticals common stock to its shareholders.

Scilex Holding Company reports a dividend distribution of Semnur Pharmaceuticals common stock to its shareholders.

WAVE Equity Partners and its affiliates have filed a Schedule 13D reporting a 10.7% beneficial ownership stake in Factorial Energy Inc. following a recent business combination.

Chairman James Comer reports a 31.7% beneficial ownership in RTB Digital following the completion of a strategic merger.

Beauty Ventures LLC and Waldencast Long-Term Capital LLC have liquidated their entire beneficial ownership in Waldencast plc.

Millstreet Capital Management and its principals have filed an amendment to their Schedule 13D, disclosing recent open market sales of Diebold Nixdorf common shares.

Glory Achievement Fund Limited has increased its beneficial ownership in Niu Technologies to 40.8% following recent open-market purchases.

Farallon Capital Management and associated individuals have reported the disposal of their entire stake in Centessa Pharmaceuticals following its acquisition by Eli Lilly.

OSN Streaming Limited has submitted a non-binding proposal to acquire all outstanding shares of Anghami Inc. not already in its possession for $3.39 per share in cash.

Warner Bros. Discovery and Dplay Entertainment have submitted a non-binding proposal to acquire all outstanding shares of Anghami Inc. for $3.39 per share.

Warner Bros. Discovery and Dplay Entertainment have submitted a non-binding proposal to acquire all outstanding shares of Anghami Inc. for $3.39 per share.

Takeover Time 2026 LLC has reported the total divestment of its entire stake in Aditxt, Inc. as of June 23, 2026.